Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN953625 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-NDRG Family Member 2 (NDRG2) (AA 41-70), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- N-Term, AA 41-70
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Expression of NDRG2 in esophageal squamous cell carcinoma.
NDRG1/2 expression is inhibited in primary acute myeloid leukemia.
NDRG2 is one of novel intrinsic factors for regulation of IL-10 production in human myeloid cell.
HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells.
NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
Shi H, Li N, Li S, Chen C, Wang W, Xu C, Zhang J, Jin H, Zhang H, Zhao H, Song W, Feng Q, Feng X, Shen X, Yao L, Zhao Q
Cancer science 2010 May;101(5):1292-9
Cancer science 2010 May;101(5):1292-9
NDRG1/2 expression is inhibited in primary acute myeloid leukemia.
Tschan MP, Shan D, Laedrach J, Eyholzer M, Leibundgut EO, Baerlocher GM, Tobler A, Stroka D, Fey MF
Leukemia research 2010 Mar;34(3):393-8
Leukemia research 2010 Mar;34(3):393-8
NDRG2 is one of novel intrinsic factors for regulation of IL-10 production in human myeloid cell.
Choi SC, Kim KD, Kim JT, Oh SS, Yoon SY, Song EY, Lee HG, Choe YK, Choi I, Lim JS, Kim JW
Biochemical and biophysical research communications 2010 Jun 4;396(3):684-90
Biochemical and biophysical research communications 2010 Jun 4;396(3):684-90
HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells.
Liu J, Zhang J, Wang X, Li Y, Chen Y, Li K, Zhang J, Yao L, Guo G
Experimental cell research 2010 Jul 15;316(12):1985-93
Experimental cell research 2010 Jul 15;316(12):1985-93
NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
Furuta H, Kondo Y, Nakahata S, Hamasaki M, Sakoda S, Morishita K
Biochemical and biophysical research communications 2010 Jan 22;391(4):1785-91
Biochemical and biophysical research communications 2010 Jan 22;391(4):1785-91
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB